儿童局灶性脑动脉病:新型严重程度评分与自然史
VIPS研究前瞻性纳入355例动脉缺血性卒中患儿,其中41例经中心确认的局灶性脑动脉病(FCA)。研究开发了基于5个动脉节段的新FCA严重程度评分(FCASS),发现最大FCASS与1年儿童卒中结局相关(P=0.037),但FCASS与复发性卒中无关。
要点
- FCASS由5个动脉节段(床突上颈内动脉、A1、A2、M1、M2)的评分无权重求和构成
- 33例有随访影像的患儿中24例(73%)出现FCA进展,最大FCASS中位7(5-9)
- 最大FCASS与1年儿童卒中结局相关(P=0.037),基线FCASS不相关
核心结论
- 新型FCA严重程度评分与VIPS队列中神经结局相关,为正在开发的FCA治疗试验提供工具。
研究设计与样本
- VIPS研究(儿童卒中感染的血管效应)前瞻性纳入355例动脉缺血性卒中患儿(2010-2014),其中41例经中心确认的FCA。
- 两名神经放射科医生独立审阅FCA脑血管影像,对单个动脉节段赋予0(无受累)至4(闭塞)的分级严重程度评分,FCASS为无权重求和。
- 通过迭代过程,对来自不同动脉节段组合的评分建模,以确定与临床结局相关性、简便性和可靠性最优的模型。
主要发现
- 最优FCASS汇总5个动脉节段的评分:床突上颈内动脉、A1、A2、M1和M2。
- 基线FCASS中位数(四分位距)为4(2-6)。
- 33例有随访影像的患儿中,最大FCASS(任何时间点)为7(5-9)。
- 24例(73%)随访时FCA进展,其最大FCASS中位时间为卒中后8(5-35.5)天,FCASS中位增加4(2.5-6)。
- FCASS与复发性动脉缺血性卒中无关;最大FCASS(而非基线FCASS)与1年儿童卒中结局指标相关(P=0.037)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Focal cerebral arteriopathy (FCA)-a common cause of arterial ischemic stroke in previously healthy children-often progresses over days to weeks, increasing the risk of recurrent stroke. We developed a novel severity scoring system designed to quantify FCA progression and correlate with clinical outcomes. Methods- The VIPS study (Vascular Effects of Infection in Pediatric Stroke) prospectively enrolled 355 children with arterial ischemic stroke (2010-2014), including 41 with centrally confirmed FCA. Two neuroradiologists independently reviewed FCA cerebrovascular imaging, assigning a graded severity score of zero (no involvement) to 4 (occlusion) to individual arterial segments. The FCA severity score (FCASS) was the unweighted sum. In an iterative process, we modeled scores derived from different combinations of arterial segments to identify the model that optimized correlation with clinical outcome, simplicity, and reliability. Results- The optimal FCASS summed scores from 5 arterial segments: supraclinoid internal carotid artery, A1, A2, M1, and M2. The median (interquartile range) baseline FCASS was 4 (2-6). Of 33 children with follow-up imaging, the maximum FCASS (at any time point) was 7 (5-9). Twenty-four (73%) had FCA progression on follow-up with their maximum FCASS at a median of 8 (5-35.5) days poststroke; their median FCASS increase was 4 (2.5-6). FCASS did not correlate with recurrent arterial ischemic stroke. Maximum (but not baseline) FCASS correlated with 1-year pediatric stroke outcome measures ( P=0.037). Conclusions- Our novel scoring system for FCA severity correlates with neurological outcomes in the VIPS cohort and provides a tool for FCA treatment trials under development.
引用
- Fullerton HJ, Stence N, Hills NK, et al. Focal Cerebral Arteriopathy of Childhood: Novel Severity Score and Natural History. Stroke. 2018. PMID: 30355212. doi:10.1161/STROKEAHA.118.021556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。